alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# EUR-Lex - 12006E206 - EN

Important legal notice

*|*

# 12006E206

**Treaty establishing the European Community (consolidated version) - Part Five - Institutions of the Community - TITLE I - Provisions governing the institutions - Chapter 1 - The institutions - Section 2 - The Council - Article 206 **

*
Official Journal C 321 E , 29/12/2006 P. 0137 - 0137 Official Journal C 325 , 24/12/2002 P. 0118 - Consolidated version Official Journal C 340 , 10/11/1997 P. 0265 - Consolidated version Official Journal C 224 , 31/08/1992 P. 0058 - Consolidated version (EEC Treaty - no official publication available) *

Article 206

Where a vote is taken, any Member of the Council may also act on behalf of not more than one other member.

--------------------------------------------------
Exhibit 99.4

                         CERTIFICATION PURSUANT TO
                SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I, Robert J. Wood, Chief Financial Officer of the Biophan Technologies,
Inc. (the "registrant"), certify that:

     1.  I have reviewed this quarterly report on Form 10-QSB of Biophan
     Technologies, Inc.;

     2.   Based on my knowledge, this quarterly report does not contain any
     untrue statement of a material fact or omit to state a material fact
     necessary to make the statements made, in light of the circumstances
     under which such statements were made, not misleading with respect to
     the period covered by this quarterly report;

     3.  Based on my knowledge, the financial statements, and other financial
     information included in this quarterly report, fairly present in all
     material respects the financial condition, results of operations and
     cash flows of the registrant as of, and for, the periods presented in
     this quarterly report;


Date:  October 15, 2002


/s/Robert J. Wood
--------------------
Robert J. Wood
Chief Financial Officer
Webinar Attendees: Energy Conservation Program: Energy Conservation Standards for Standby Mode and Off Mode for Microwave Ovens Meeting

Meeting Date: Wednesday, March 14, 2012

Name Title Organization Street City State Zip Phone Fax Email

Baker, David Counsel, GR and 

Regulatory Compliance

GE AP2-222 Louisville KY 40225 N/A N/A david.baker2@ge.com

Ballo, Timothy Associate Attorney Earthjustice 1625 Massachusetts 

Avenue NW

Suite 702

Washington DC 20036 202-667-4500 202-667-2356 tballo@earthjustice.org

Fassler, Richard S Manager, Energy 

Efficiency Programs

Power Integrations 5245 Hellyer Avenue San Jose CA 95138 408-963-1816 408-414-8973 rfassler@powerint.com

Gracki, John Senior Engineer Samsung Electronics 935 National Parkway Schaumburg IL 60173 N/A N/A jgracki@sea.samsung.com

Johnson, 

Christopher

Sr. Manager, Standards 

& Compliance

LG Electronics USA, Inc 1000 Sylvan Ave Englewood 

Cliffs

NJ 07632 201-266-2419 N/A chris.johnson@lge.com

Kline, Kelley Global Product 

Stewardship Program 

Manager

GE Appliance Park, AP35-1104 Louisville KY 40056 502-452-7603 N/A kelley.kline@ge.com

Nsofor, Kenneth Senior Consultant Navigant Consulting 77 S. Bedford Street

Suite 400

Burlington MA 01803 781-270-8338 N/A kenneth.nsofor@navigantconsulting.com

Petruska, Steve Senior Product Safety 

Engineer

Sharp Electronics Corporation One Sharp Plaza Mahwah NJ 07495 N/A N/A spetrusk@sharpsec.com

Polinski, Steve Senior Manager 

Regulatory Affairs

Miele, Inc. 9 Independence Way Princeton NJ 08540 609-419-9898 609-419-0147 spolinski@mieleusa.com

Polley, Nolan Lead Engineer, Food 

Preparation Controls - 

North American Region

Whirlpool Corporation 451 Renaissance Drive Saint Joseph MI 49085 N/A N/A nolan_a_polley@whirlpool.com

Vazquez, George Engineer Panasonic 5201 Tollview Drive Rolling 

Meadows

IL 60008 N/A N/A george.vazquez.@us.panasonic.com

Williams, Yoolanda Program Manager - 

Regulatory and 

Compliance

General Electric AP2-126, Appliance Park Louisville KY 40225 N/A N/A yoolanda.williams@ge.com

Yamashita, Sei Manager Panasonic 5201 Tollview Dr Rolling 

Meadows

IL 60008 N/A N/A sei.yamashita@us.panasonic.com
#### § 201.55 Retests.

Retests shall be made as follows:

(a) When the range of 100-seed replicates of a given test exceeds the maximum tolerated range in the table appearing in this section.

Table of Maximum Tolerated Ranges Between 100-Seed Replicates for Use in Connection With [§ 201.55(A)](/on/2024-09-20/title-7/section-201.55#p-201.55(A))

| Average percent germinations | | Maximum allowed between replicates | |
| --- | --- | --- | --- |
| | | 4 replicates | 2 replicates |
| 99 | 2 | 5 | |
| 98 | 3 | 6 | |
| 97 | 4 | 7 | 6 |
| 96 | 5 | 8 | 6 |
| 95 | 6 | 9 | 7 |
| 94 | 7 | 10 | 8 |
| 93 | 8 | 10 | 8 |
| 92 | 9 | 11 | 9 |
| 91 | 10 | 11 | 9 |
| 90 | 11 | 12 | 9 |
| 89 | 12 | 12 | 10 |
| 88 | 13 | 13 | 10 |
| 87 | 14 | 13 | 11 |
| 86 | 15 | 14 | 11 |
| 85 | 16 | 14 | 11 |
| 84 | 17 | 14 | 11 |
| 83 | 18 | 15 | 12 |
| 82 | 19 | 15 | 12 |
| 81 | 20 | 15 | 12 |
| 80 | 21 | 16 | 13 |
| 79 | 22 | 16 | 13 |
| 78 | 23 | 16 | 13 |
| 77 | 24 | 17 | 13 |
| 76 | 25 | 17 | 13 |
| 75 | 26 | 17 | 14 |
| 74 | 27 | 17 | 14 |
| 73 | 28 | 17 | 14 |
| 72 | 29 | 18 | 14 |
| 71 | 30 | 18 | 14 |
| 70 | 31 | 18 | 14 |
| 69 | 32 | 18 | 14 |
| 68 | 33 | 18 | 15 |
| 67 | 34 | 18 | 15 |
| 66 | 35 | 19 | 15 |
| 65 | 36 | 19 | 15 |
| 64 | 37 | 19 | 15 |
| 63 | 38 | 19 | 15 |
| 62 | 38 | 19 | 15 |
| 61 | 40 | 19 | 15 |
| 60 | 41 | 19 | 15 |
| 59 | 42 | 19 | 15 |
| 58 | 43 | 19 | 15 |
| 57 | 44 | 19 | 15 |
| 56 | 45 | 19 | 15 |
| 55 | 46 | 20 | 15 |
| 54 | 47 | 20 | 16 |
| 53 | 48 | 20 | 16 |
| 52 | 48 | 20 | 16 |
| 51 | 50 | 20 | 16 |

(b) When at the time of the prescribed final count there are indications, such as presence of firm ungerminated seeds, that a satisfactory germination has not been obtained;

(c) When there is evidence that the results may not be reliable due to improper test conditions, errors in seedling evaluation, the presence of fungi or bacteria, or inaccuracies in counting or recording results;

(d) When a sample shows seedling injury or abnormality as a result of chemical treatment, of exposure to chemicals, or of toxicity from any source. (Retest shall be made in soil or a mixture of soil and sand);

(e) When no two satisfactory tests are within tolerance.

Note to [§ 201.55](/on/2024-09-20/title-7/section-201.55):

To find the maximum tolerated range, compute the average percentage of all 100 seed replicates of a given test, rounding off the result to the nearest whole number. The germination is found in the first two columns of the table. When the differences between highest and lowest replicates do not exceed the corresponding values found in the “4 replicates” column, no additional testing is required. However, if the differences exceed the values in the “4 replicates” column, retesting is necessary.

[[25 FR 8771](https://www.federalregister.gov/citation/25-FR-8771), Sept. 13, 1960, as amended at [65 FR 1707](https://www.federalregister.gov/citation/65-FR-1707), Jan. 11, 2000]
# EUR-Lex - 12002M046 - EN

Avis juridique important

*|*

# 12002M046

**Treaty on European Union (Nice consolidated version) - Title VIII: Final provisions - Article 46 - Article L - EU Treaty (Maastricht 1992) - **

*
Official Journal C 325 , 24/12/2002 P. 0030 - 0030 Official Journal C 340 , 10/11/1997 P. 0170 - Consolidated version Official Journal C 191 , 29/07/1992 P. 0063 *

Treaty on European Union (Nice consolidated version)

Title VIII: Final provisions

Article 46

Article L - EU Treaty (Maastricht 1992)

Article 46

The provisions of the Treaty establishing the European Community, the Treaty establishing the European Coal and Steel Community and the Treaty establishing the European Atomic Energy Community concerning the powers of the Court of Justice of the European Communities and the exercise of those powers shall apply only to the following provisions of this Treaty:

(a) provisions amending the Treaty establishing the European Economic Community with a view to establishing the European Community, the Treaty establishing the European Coal and Steel Community and the Treaty establishing the European Atomic Energy Community;

(b) provisions of Title VI, under the conditions provided for by Article 35;

(c) provisions of Title VII, under the conditions provided for by Articles 11 and 11a of the Treaty establishing the European Community and Article 40 of this Treaty;

(d) Article 6(2) with regard to action of the institutions, in so far as the Court has jurisdiction under the Treaties establishing the European Communities and under this Treaty;

(e) the purely procedural stipulations in Article 7, with the Court acting at the request of the Member State concerned within one month from the date of the determination by the Council provided for in that Article;

(f) Articles 46 to 53.
<PAGE>
                                                                    Exhibit 31.1

                                 CERTIFICATIONS

I, William C. Brooks, certify that:

1. I have reviewed this annual report on Form 10-K of United American Healthcare
Corporation;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

      a) designed such disclosure controls and procedures to ensure that
      material information relating to the registrant, including its
      consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this annual report is
      being prepared;

      b) evaluated the effectiveness of the registrant's disclosure controls and
      procedures as of a date within 90 days prior to the filing date of this
      annual report (the "Evaluation Date"); and

      c) presented in this annual report our conclusions about the effectiveness
      of the disclosure controls and procedures based on our evaluation as of
      the Evaluation Date;

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

      a) all significant deficiencies in the design or operation of internal
      controls which could adversely affect the registrant's ability to record,
      process, summarize and report financial data and have identified for the
      registrant's auditors any material weaknesses in internal controls; and

      b) any fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant's internal
      controls;

<PAGE>

6. The registrant's other certifying officer and I have indicated in this annual
report whether there were significant changes in internal controls or in other
factors that could significantly affect internal controls subsequent to the date
of our most recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.

Date: August 26, 2004

                             /s/ William C. Brooks
                             ---------------------------
                             President and Chief Executive Officer
                            (principal executive officer)
# EUR-Lex - 12006E/PRO/13 - EN

Important legal notice

*|*

# 12006E/PRO/13

**Treaty establishing the European Community (consolidated version) - D. Protocols annexed to the Treaty establishing the European Community - Protocol (No 13) on goods originating in and coming from certain countries and enjoying special treatment when imported into a Member State (1957) **

*
Official Journal C 321 E , 29/12/2006 P. 0250 - 0250 *

Protocol (No 13)

on goods originating in and coming from certain countries and enjoying special treatment when imported into a Member State (1957)

THE HIGH CONTRACTING PARTIES

DESIRING to define in greater detail the application of this Treaty to certain goods originating in and coming from certain countries and enjoying special treatment when imported into a Member State,

HAVE AGREED upon the following provisions, which shall be annexed to this Treaty:

1. The application of the Treaty establishing the European Economic Community shall not require any alteration in the customs treatment applicable on 1 January 1958 to imports into the Benelux countries of goods originating in and coming from Surinam [*] or the Netherlands Antilles; [**]

2. Goods imported into a Member State and benefiting from the treatment referred to above shall not be considered to be in free circulation in that State within the meaning of Article 24 of this Treaty when re-exported to another Member State.

3. Member States shall communicate to the Commission and to the other Member States their rules governing the special treatment referred to in this Protocol, together with a list of the goods entitled to such treatment.

They shall also inform the Commission and the other Member States of any changes subsequently made in those lists or in the treatment.

4. The Commission shall ensure that the application of these rules cannot be prejudicial to other Member States; to this end it may take any appropriate measures as regards relations between Member States.

Done at Rome this twenty-fifth day of March in the year one thousand nine hundred and fifty-seven.

[*] The provisions of Part Four of the Treaty were applied to Surinam, by virtue of a Supplementary Act of the Kingdom of the Netherlands to complete its instrument of ratification, from 1 September 1962 to 16 July 1976.

[**] In accordance with Article 1 of the Convention of 13 November 1962 amending the Treaty establishing the European Economic Community (OJ L 150, 1.10.1964, p. 2414), the Protocol no longer applies to the Netherlands Antilles.

--------------------------------------------------
# EUR-Lex - 12006M022 - EN

Important legal notice

*|*

# 12006M022

**Treaty on European Union (consolidated version) - Title V - Provisions on a common foreign and security policy - Article 22 **

*
Official Journal C 321 E , 29/12/2006 P. 0019 - 0019 Official Journal C 325 , 24/12/2002 P. 0017 - Consolidated version Official Journal C 340 , 10/11/1997 P. 0160 - Consolidated version *

Article 22

1. Any Member State or the Commission may refer to the Council any question relating to the common foreign and security policy and may submit proposals to the Council.

2. In cases requiring a rapid decision, the Presidency, of its own motion, or at the request of the Commission or a Member State, shall convene an extraordinary Council meeting within 48 hours or, in an emergency, within a shorter period.

--------------------------------------------------
I

103D CONGRESS

1ST SESSION H. R. 577

To amend the Internal Revenue Code of 1986 to increase and make permanent the deduction for the health insurance costs of self-employed individuals.

IN THE HOUSE OF REPRESENTATIVES

JANUARY 26, 1993

Mr. BEREUTER introduced the following bill; which was referred to the

Committee on Ways and Means

A BILL

To amend the Internal Revenue Code of 1986 to increase

and make permanent the deduction for the health insurance costs of self-employed individuals.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DEDUCTION FOR THE HEALTH INSURANCE

4 COSTS OF SELF-EMPLOYED INDIVIDUALS IN5 CREASED AND MADE PERMANENT.

6 (a) DEDUCTION INCREASED.—Paragraph (1) of sec7 tion 162(l) of the Internal Revenue Code of 1986 (relating

8 to special rules for health insurance costs of self-employed
2

•HR 577 IH

1 individuals) is amended by striking ‘‘25 percent’’ and in2 serting ‘‘50 percent’’.

3 (b) DEDUCTION MADE PERMANENT.—Subsection (l)

4 of section 162 of such Code is amended by striking para5 graph (6).

6 (c) REPEAL OF TRANSITION RULE.—Subsection (a)

7 of section 110 of the Tax Extension Act of 1991 is

8 amended by striking paragraph (2).

9 (d) EFFECTIVE DATE.—The amendments made by

10 this section shall apply to taxable years beginning after

11 December 31, 1991.

Æ
Exhibit 10.2
AMENDMENT TO EMPLOYMENT AGREEMENT
​
This Amendment to Employment Agreement (this "Amendment"), effective June 23, 2020, amends the Employment Agreement (as amended from time to time, the "Agreement") by and between Brainstorm Cell Therapeutics Ltd. and Uri Yablonka.
​
NOW, THEREFORE, in consideration of the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
​
1.    Section 3.1 of the Agreement is hereby amended and restated as follows:
​
“3.1 Salary.  In consideration for Employee’s obligations under this Agreement, Company shall pay Employee an annual base salary of 640,000 NIS per year, payable in accordance with the Company’s regular payroll practices (e.g., timing of payments and standard employee deductions, such as income and employment tax withholdings) and as required by law.
​
IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the date set forth above.
​
	​


	​


	​


	​



	BRAINSTORM CELL THERAPEUTICS LTD.
	    
	​

	​
	​
	​

	By:
	/s/ Alla Patlis
	​
	/s/ Uri Yablonka

	Name:
	Alla Patlis
	​
	Uri Yablonka

	Title:
	Controller
	​
	​



​
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-START>                             SEP-01-1999
<PERIOD-END>                               FEB-29-2000
<CASH>                                         397,384
<SECURITIES>                                         0
<RECEIVABLES>                                  238,699
<ALLOWANCES>                                         0
<INVENTORY>                                      7,588
<CURRENT-ASSETS>                               687,996
<PP&E>                                         123,679
<DEPRECIATION>                                  37,743
<TOTAL-ASSETS>                                 781,122
<CURRENT-LIABILITIES>                        4,314,701
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        900
<COMMON>                                           760
<OTHER-SE>                                 (3,535,239)
<TOTAL-LIABILITY-AND-EQUITY>                   781,122
<SALES>                                        304,920
<TOTAL-REVENUES>                               331,125
<CGS>                                          164,309
<TOTAL-COSTS>                                  164,309
<OTHER-EXPENSES>                             5,204,592
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (5,037,776)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (5,037,776)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (5,037,776)
<EPS-BASIC>                                     (0.66)
<EPS-DILUTED>                                   (0.66)


</TABLE>
EXHIBIT 21
                             ROBERTSON-CECO CORPORATION
                           SUBSIDIARIES OF THE REGISTRANT
                                  DECEMBER 31, 1996

-----------------------------------------------------------------------------
                                        JURISDICTION
COMPANY                                 OF INCORPORATION
-----------------------------------------------------------------------------

Subsidiaries of the registrant included in the
respective consolidated financial statements:

                         DOMESTIC

Ceco Dallas Co.                         Texas
Ceco Houston Co.                        Texas
Ceco San Antonio Co.                    Texas
M C Durham Co.                          North Carolina
M C Windsor Co.                         Arkansas
Meyerland Co.                           Colorado
Robertson-Ceco Industries, Inc.         Delaware
Star Construction Company               Oklahoma
Star Building Systems, Inc.             Oklahoma

                         FOREIGN

H. H. Robertson, Inc.                   Ontario
#### Hartington National Bank, appellee, v. L. L. Giles, appellant.

Filed September 26, 1913.

No. 17,327.

1. Appeal: Exclusion of Evidence: Harmless Error. The exclusion of competent evidence at one stage of a trial is not prejudicially erroneous if the facts sought to be proved are subsequently established.

2. Bills and Notes: Action: Defense of No Consideration. Under the facts stated in the opinion, *held*that the defense of no consideration was not established.

Appeal from the district court for Cedar county: Guy T. Graves, Judge.

*Affirmed.*

*E. E. Burkett}*for appellant.

*301P. *F. O'Gara, contra.*

Letton, J.

Action on promissory note brought by the indorsee. The defense is that the note was given without consideration, and that the plaintiff is not a *bona fide*holder for value, but knew at the time it was purchased that there was no consideration given for its execution; It is also alleged that plaintiff bank is not the real party in interest. The note, which is for $32.10, is dated August 9, 1909, The cashier of the plaintiff bank testified that he purchased the note of one Turley on August 12, 1909, at a price that would net the bank 10 per cent, interest. It appears that the note was executed payable to one Turley, who was an agent for the Security Mutual Life Insurance Company, in payment for life insurance; that at the time it was made and delivered Mr. Kimball, the cashier of the plaintiff bank, was present and introduced Turley to Giles; that what is termed by insurance men a “binding receipt” for the note was given Giles, which stated that he was required to take and pass a medical examination before the policy would issue; and that Giles refused and neglected to present himself for such examination. Kim-ball had an agreement with Turley that he was to receive 20 per cent, of the proceeds for his introduction and assistance in procuring the insurance contract. The note was bought three days after its execution.

Defendant complains that^ the court excluded testimony offered by him to prove certain of the facts before related. Since the facts all came out eventually, no prejudicial error occurred by this exclusion.

We are of opinion that the defense of no consideration was not established. The note was given in consideration of a contract of insurance, conditioned, it is true, but none the less a contract, and no breach or failure had occurred at the time of the purchase. If there was a breach of the contract, it was made by Giles when he *302refused to take the medical examination. The facts do not bring the case within the doctrine of the North Dakota case relied upon by defendant. *Bank v. Garceau,*22 N. Dak. 576. In that case the defendant performed his duty under the contract, duly offered himself for examination, • and was rejected by the medical examiner, while in this case the default was wilfully made by the defendant.

The district court properly held no defense had been established, and its judgment is

Affirmed.

Rose, Fawcett and Hamer, JJ., not sitting.